comparemela.com

Latest Breaking News On - Adxn - Page 1 : comparemela.com

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Down 14.3% in December

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 3,600 shares, a drop of 14.3% from the November 30th total of 4,200 shares. Based on an average trading volume of 8,100 shares, […]

Switzerland
Addex-therapeutics-ltd
Armistice-capital
Addex-therapeutics-company-profile
Get-free-report
Addex-therapeutics
Free-report
Therapeutics-ltd
Addex-therapeutics-daily
Nasdaq-adxn
Adxn

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Down 95.4% in October

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 5,300 shares, a decrease of 95.4% from the September 30th total of 115,900 shares. Based on an average daily trading volume, of 4,000 […]

Switzerland
Nasdaq
Addex-therapeutics-ltd
Virtu-financial
Securities-exchange-commission
Addex-therapeutics-company-profile
Get-free-report
Addex-therapeutics
Free-report
Therapeutics-ltd
Addex-therapeutics-daily

Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Up 76.1% in September

Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 178,200 shares, a growth of 76.1% from the August 31st total of 101,200 shares. Based on an average daily trading volume, of 53,800 […]

Switzerland
Exchange-commission
Mission-capital
Addex-therapeutics-company-profile
Addex-therapeutics-ltd
Get-free-report
Addex-therapeutics
Free-report
Therapeutics-ltd
Addex-therapeutics-daily
Nasdaq-adxn

Brokers Issue Forecasts for Addex Therapeutics Ltd's FY2024 Earnings (NASDAQ:ADXN)

Addex Therapeutics Ltd (NASDAQ:ADXN – Free Report) – Equities researchers at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of Addex Therapeutics in a research report issued on Monday, September 25th. HC Wainwright analyst R. Selvaraju anticipates that the company will earn ($0.59) per share for the year. HC Wainwright currently […]

Switzerland
Virtu-financial
Addex-therapeutics-ltd
Securities-exchange-commission
Free-report
Addex-therapeutics
Get-free-report
Therapeutics-ltd
Addex-therapeutics-daily
Nasdaq-adxn
Adxn

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.